Mauna Kea Technologies: 2026 Financial Calendar Unveiled

Mauna Kea Technologies, known for its Cellvizio® endomicroscopy platform, has announced its financial calendar for 2026. This program includes the release of its 2025 annual results on April 9, and a series of quarterly and semi-annual reports. The company plans to reconnect with the financial community by participating in various investor forums. These events, such as the Allinvest Securities Biomed Forum and the TP ICAP Midcap Annual Conference, will provide an opportunity to share information about recent restructurings and strategic partnerships, which began in 2025. Sacha Loiseau, the company's CEO, emphasizes the importance of these interactions to showcase its progress and growth prospects.